People: Catalyst Pharmaceutical Partners Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

2.89USD
19 Dec 2014
Price Change (% chg)

$0.04 (+1.40%)
Prev Close
$2.85
Open
$2.85
Day's High
$2.90
Day's Low
$2.79
Volume
208,182
Avg. Vol
1,004,083
52-wk High
$3.49
52-wk Low
$1.70

Search Stocks

Miller, Steven 

Brief Biography

Dr. Steven R. Miller, Ph.D. is Chief Operating Officer, Chief Scientific Officer of Catalyst Pharmaceutical Partners Inc. Previously, commencing in April 2007, Dr. Miller was our Vice President of Pharmaceutical Development and Project Management. Dr. Miller has worked in the healthcare industry for over 25 years. Prior to joining us, Dr. Miller spent 15 years with various divisions of Watson Laboratories, a subsidiary of Watson Pharmaceuticals, Inc., most recently as Executive Director of R&D Operations. In this capacity, Dr. Miller managed a team of 75 in the testing of all R&D products for clinical trials, including method valuation, stability testing, operation of the R&D pilot plant, and assembly of the CMC section of drug applications, in addition to other responsibilities. Prior to this position, Dr. Miller was Director of Technology Transfer for Watson Laboratories, and Vice President of Research and Product Development for Royce Laboratories, which was subsequently acquired by Watson Laboratories. Prior to joining Royce Laboratories, Dr. Miller was Group Leader and Senior Scientist at Dade Behring. Prior to that, he served as an Analytical Chemist at the U.S. Food & Drug Administration. Dr. Miller received his Bachelor of Science Degree in Chemistry from the University of Maryland and his Ph.D. from the University of Miami.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
309,406 -- 9,400 318,806

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick McEnany

426,512

Alicia Grande

239,800

Steven Miller

318,806

David Muth

--

M. Douglas Winship

258,429

David Caponera

--
As Of 30 Dec 2013
Search Stocks